Aurobindo Pharma submits ANDA for generic dolutegravir

Aurobindo Pharma, in conjunction with ViiV Healthcare and the Clinton Health Access Initiative Inc., have announced that Aurobindo has submitted an ANDA for generic dolutegravir to the FDA. Dolutegravir is a drug that is used to treat patients suffering from HIV. If the FDA approves the application, Aurobindo will begin to supply the generic version of the drug for the President’s Emergency Plan for AIDS Relief program.


Read the source article at Yahoo! Finance